AIIMS-ISRO Partner to Advance Space Medicine Research

AIIMS-ISRO Partner to Advance Space Medicine Research

Why in News? 

Recently, All India Institute of Medical Sciences (AIIMS) and Indian Space Research Organisation (ISRO) partnered to boost space medicine research, focusing on crew health for India’s human space missions, including Gaganyaan and the Bharatiya Antariksh Station. 

Key Research Areas Under The AIIMS-ISRO Partnership 

• • Space Physiology: AIIMS will conduct deep research into how microgravity affects the human body. Scientists will monitor cardiovascular shifts and autonomic nervous system changes. This data will help predict how heart and lung functions will react during long-duration orbital stays.
  • Bone Health: Experts will study musculoskeletal atrophy and bone density loss. Since space mimics accelerated aging, this pact will create exercise protocols and nutritional countermeasures. These findings will also lead to new treatments for osteoporosis on Earth.

• Genomics Research: Another major component is research on immunity, microbiome dynamics, genomics, and biomarkers in space environments. These studies aim to understand how space radiation, isolation, and microgravity affect immune responses and genetic expression.

• Mental Wellness: The partnership will develop psychological support systems for isolated crews. Researchers will create psychometric tools for astronaut selection. They will also implement behavioral health monitoring to manage the stress of long-term confinement in deep space. 
• Smart Devices: ISRO and AIIMS will co-develop indigenous medical devices for zero-gravity use. These will include AI-powered health monitors and portable diagnostic tools. These devices will ensure the medical self-reliance of Indian astronauts during emergency situations. 
• Clinical Training: AIIMS will provide specialized clinical training for flight surgeons and crew. They will simulate space-like medical emergencies to prepare the team. This will build a robust human spaceflight health ecosystem.

Importance of Space Medicine in Human Spaceflight

• Radiation Protection: Space medicine mitigates ionizing radiation risks, which are 100 times higher than on Earth. Astronauts face increased cancer risks and DNA damage. Protective protocols involve pharmacological countermeasures to shield the central nervous system from solar particle events.

• Vision Impairment: Approximately 70% of astronauts experience optic disc Spaceflight-Associated Neuro-ocular Syndrome (SANS) edema due to cephalad fluid shifts. Space medicine develops lower body negative pressure (LBNP) devices to redistribute fluids and prevent permanent visual acuity loss.

• Immune Dysregulation: Studies show that spaceflight causes immune system suppression, making latent viruses like Epstein-Barr reactivate. Space medicine utilizes biomedical markers to track white blood cell changes, ensuring astronauts don’t succumb to simple infections during deep-space transit.

• Circadian Regulation: Astronauts on the ISS experience 16 sunrises daily, disrupting circadian rhythms. Space medicine implements blue-enriched LED lighting and melatonin protocols to prevent insomnia and cognitive fatigue, which are responsible for nearly 5% of mission errors.

• Pharmacokinetics Alteration: Space medicine tracks drug stability and metabolic rates, as shelf-lives decrease due to radiation. Research ensures that analgesics and antibiotics remain potent for the 30-month duration required for a Mars mission.

• Genetic Expression: The NASA Twins Study proved that 7% of gene expression may not return to normal after flight. Space medicine uses epigenetics to understand long-term telomere changes, ensuring that “space-grown” biological shifts do not lead to chronic diseases post-landing.

Significance of the AIIMS–ISRO Partnership

• Gaganyaan Programme: The partnership will provide critical medical support for the three-member crew of the Gaganyaan mission. AIIMS’s research on microgravity’s effects on human physiology will ensure astronaut safety during the planned 3-day mission at a 400 km orbit.
• Bharatiya Antariksh Station (BAS): Supporting the establishment of the five-module BAS by 2035, AIIMS will develop medical protocols. Research focuses on musculoskeletal atrophy and immune system changes essential for the first module (BAS-01) launch slated for 2028. 
• Lunar Exploration Capability: To support the goal of a crewed lunar landing by 2040, this collaboration tackles the challenges of deep-space radiation and prolonged isolation. The joint studies will create the medical framework necessary for sustained Lunar outposts. 
• Indigenous Technology: By fostering interdisciplinary R&D, the pact reduces reliance on foreign space agencies like NASA. It promotes the development of indigenous medical devices, strengthening India’s bioeconomy, which is projected to reach $250 billion. 
• Healthcare Innovation on Earth: Space-derived insights into bone density loss will revolutionize treatments for osteoporosis and geriatric conditions on Earth. Technologies like telemedicine and leg blood flow devices developed for space will be adapted for general clinical use.
• Vision of Viksit Bharat 2047: This partnership aligns with the Space Vision 2047 to make India a “Vishwaguru” (global leader) in space medicine. This collaboration positions the nation as a hub for scientific innovation, benefiting not just India but humankind as a whole.